Schmidt Eric Thomas (CIK 0001754403)

Latest company ownership

ALLO - Allogene Therapeutics, Inc.

Role: CFO

Shares held

1,152,595

Last filed at

Mar 24, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 14, 2023	Mar 16, 2023	Allogene Therapeutics, Inc.	CFO	Sell	42.5	-35,879	-2.40%	✗	$196.3K
Mar 15, 2022	Mar 17, 2022	Allogene Therapeutics, Inc.	CFO	Sell	45.0	-11,469	-0.91%	✗	$87.6K
Mar 15, 2021	Mar 17, 2021	Allogene Therapeutics, Inc.	CFO	Sell	42.5	-8,053	-0.65%	✗	$307.9K
Jan 14, 2021	Jan 19, 2021	Allogene Therapeutics, Inc.	CFO	Sell	38.8	-30,000	-2.38%	✓	$945.5K
Nov 16, 2020	Nov 18, 2020	Allogene Therapeutics, Inc.	CFO	Sell	42.5	-15,000	-1.18%	✓	$493.1K
Oct 15, 2020	Oct 16, 2020	Allogene Therapeutics, Inc.	CFO	Sell	42.5	-15,000	-1.16%	✓	$607.4K
Sep 21, 2020	Sep 22, 2020	Allogene Therapeutics, Inc.	CFO	Sell	42.5	-15,000	-1.15%	✓	$529.5K
Mar 16, 2020	Mar 18, 2020	Allogene Therapeutics, Inc.	CFO	Sell	47.5	-5,450	-0.41%	✗	$107.5K
Feb 20, 2020	Feb 24, 2020	Allogene Therapeutics, Inc.	CFO	Sell	16.3	-237,155	-15.63%	✗	$6M